Patterson Companies reported a 1.6% increase in net sales to $1.65 billion and GAAP earnings of $0.42 per diluted share for the second quarter of fiscal year 2024. The company's performance was driven by strong dental consumables growth, offset by lower sales in certain high-tech dental equipment categories. The Animal Health segment benefited from a diverse offering and omnichannel presence.
Second quarter net sales increased 1.6% year-over-year to $1.65 billion.
Internal sales increased 1.0% year-over-year, driven by dental consumables growth of 2.9%.
GAAP earnings were $0.42 per diluted share, and adjusted earnings were $0.50 per diluted share.
Returned $85.9 million to shareholders through dividends and share repurchases.
Patterson Companies revised its fiscal 2024 earnings guidance, expecting GAAP earnings in the range of $2.04 to $2.14 per diluted share and non-GAAP adjusted earnings in the range of $2.35 to $2.45 per diluted share.
Visualization of income flow from segment revenue to net income